Joint Working archives

Completed Roche Joint Working Projects

       
Project Title Start Date Organisations involved Executive Summary (PDF)
Development of a best practice pathway for Advanced Breast cancer. January 2017 The Christie NHS Foundation Trust and Roche Products Ltd. (398KB)
Development of Metastatic Breast Cancer Data Infrastructure October 2016 Brighton & Sussex University Hospitals Trust and Roche Products Ltd. (375KB)
Development of an objective assessment protocol for elderly patients with lymphoma and a discharge protocol for outpatients with diffuse large B cell lymphoma. November 2016 Guy’s & St Thomas’ NHS Foundation Trust and Roche Products Ltd.
(39KB)
Costed pathway for early and advanced breast cancer in East Midlands Strategic Clinical network (EMSCN) March 2016

East Midlands Strategic Clinical Network & Roche Products Ltd. (397KB)
A costed Follicular Lymphoma pathway July 2015 Hull & East Yorkshire NHS Trust & The University of York (208KB)
Proof of concept idiopathic pulmonary fibrosis (IPF) pathway step changes and development of an IPF specific patient reported experience measures. December 2015 Imperial College Healthcare NHS Trust and Roche Products Ltd. (193KB)
Improving Outcomes for Cancer Patients – demonstrating utility and value of the mandated Systemic Anti-Cancer Therapy (SACT) Dataset through automated reports October 2014 Imperial College Healthcare NHS Trust & Roche Products Ltd. (36KB)
Quantifying the use of NHS Healthcare resource for patients with Inflammatory Arthritis, comparing high and low/remission disease states May 2015 Guy’s & St Thomas’ NHS Foundation Trust and Roche Products Ltd (238KB)
Improving Outcomes for Cancer Patients – supporting development of a national Systemic Anti-Cancer Therapy Dataset for Wales through automated reports June 2015 Singleton Hospital, Part of Abertawe Bro Morgannwg University Health Board; Velindre NHS Trust; Hywel Dda University Health Board; South Wales Cancer Network and Roche Products Ltd. (49KB)
Improving Outcomes for Cancer Patients – supporting development of a national Systemic Anti-Cancer Therapy Dataset for Wales through automated reports June 2015 Betsi Cadwaladr University Health Board and Roche Products Ltd. (47KB)
A costed colorectal cancer (CRC) pathway August 2011 Bristol PCT, Avon Somerset & Wiltshire Cancer Services (ASWCS) & Roche Products Limited (RPL) (55 KB)
Service Evaluation Nottingham (management of follicular lymphoma) December 2011 Nottingham University Hospitals (City Campus) & Roche Products Limited (RPL) (54 KB)
Service Evaluation at The Royal Marsden NHS Foundation Trust April 2012 The Royal Marsden NHS Foundation Trust and Roche Products Limited (55 KB)
Change Management Checklist and Metrics to Measure and Improve Cancer Patients’ Experience July 2012 London Cancer and Roche Products Limited (25 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy Dataset June 2013 East and North Hertfordshire NHS Trust and Roche Products Ltd (35 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy (SACT) Dataset June 2013 East of England Strategic Clinical Network and Roche Products Ltd (35 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy (SACT) Dataset October 2013 Oxford University Hospitals NHS Trust and Roche Products Ltd. (46 KB)
A costed Diffuse Large B Cell Lymphoma(DLBCL) pathway October 2013 Hull & East Yorkshire NHS Trust, The University of York & Roche Products Ltd (RPL) (75 KB)
SACT - Summary of SACT Joint Working Projects October 2013 Roche Products Ltd and NHS (34 KB)
Commissioning for Quality in Rheumatoid Arthritis November 2013 CQRA and Roche (359 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy Dataset January 2014 The Christie NHS Foundation Trust and Roche Products Ltd. (41 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy (SACT) Dataset March 2014 Imperial College Healthcare NHS Trust and Roche Products Ltd. (49 KB)
SACT - Improving Outcomes for Cancer Patients – supporting development of a national Systemic Anti-Cancer Therapy (SACT) Dataset for Wales May 2014 Singleton Hospital, Swansea; (part of ABMU Health Board ), Velindre NHS Trust and Roche Products Ltd (36KB)
SACT: Improving Outcomes for Cancer Patients – demonstrating utility and value of the mandated Systemic Anti-Cancer Therapy (SACT) Dataset through automated reports) June 2014 East and North Hertfordshire NHS Trust and Roche Products Ltd. (35KB)
Improving Outcomes for Cancer Patients – supporting development of a national Systemic Anti-Cancer Therapy (SACT) Dataset for Wales October 2014 SWCN: Hywel Dda University Health Board & Roche Products Ltd (35KB)
Development of a tool to measure impact on quality of life for a patient with advanced stage Melanoma December 2014 East & North Hertfordshire NHS Trust (E&NHNHST) & Roche Products Ltd. (61KB)
Improving routine follow up in patients with Inflammatory Arthritis and developing efficient pathways for biological therapies use December 2014 Salford Royal NHS Foundation Trust and Roche Products Ltd (282 KB)
Investigation into the Pharmaceutical Price Regulation Scheme’s Potential Impact on Innovation Adoption January 2015 The Great Manchester Academic Health Science Network and Roche Products Ltd (278KB)
Improving Outcomes for Cancer Patients – demonstrating utility and value of the mandated Systemic Anti-Cancer Therapy (SACT) Dataset through automated reports August 2015 The Christie NHS Foundation Trust and Roche Products Ltd. (371KB)

For further information on existing Joint Working projects or to explore Joint Working opportunities with Roche pleasecontact us.